Potential distributions of Bacillus anthracis and Bacillus cereus biovar anthracis causing anthrax in Africa.
Journal
PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488
Informations de publication
Date de publication:
03 2020
03 2020
Historique:
received:
11
03
2019
accepted:
11
02
2020
revised:
19
03
2020
pubmed:
10
3
2020
medline:
14
5
2020
entrez:
10
3
2020
Statut:
epublish
Résumé
Bacillus cereus biovar anthracis (Bcbva) is an emergent bacterium closely related to Bacillus anthracis, the etiological agent of anthrax. The latter has a worldwide distribution and usually causes infectious disease in mammals associated with savanna ecosystems. Bcbva was identified in humid tropical forests of Côte d'Ivoire in 2001. Here, we characterize the potential geographic distributions of Bcbva in West Africa and B. anthracis in sub-Saharan Africa using an ecological niche modeling approach. Georeferenced occurrence data for B. anthracis and Bcbva were obtained from public data repositories and the scientific literature. Combinations of temperature, humidity, vegetation greenness, and soils values served as environmental variables in model calibrations. To predict the potential distribution of suitable environments for each pathogen across the study region, parameter values derived from the median of 10 replicates of the best-performing model for each pathogen were used. We found suitable environments predicted for B. anthracis across areas of confirmed and suspected anthrax activity in sub-Saharan Africa, including an east-west corridor from Ethiopia to Sierra Leone in the Sahel region and multiple areas in eastern, central, and southern Africa. The study area for Bcbva was restricted to West and Central Africa to reflect areas that have likely been accessible to Bcbva by dispersal. Model predicted values indicated potential suitable environments within humid forested environments. Background similarity tests in geographic space indicated statistical support to reject the null hypothesis of similarity when comparing environments associated with B. anthracis to those of Bcbva and when comparing humidity values and soils values individually. We failed to reject the null hypothesis of similarity when comparing environments associated with Bcbva to those of B. anthracis, suggesting that additional investigation is needed to provide a more robust characterization of the Bcbva niche. This study represents the first time that the environmental and geographic distribution of Bcbva has been mapped. We document likely differences in ecological niche-and consequently in geographic distribution-between Bcbva and typical B. anthracis, and areas of possible co-occurrence between the two. We provide information crucial to guiding and improving monitoring efforts focused on these pathogens.
Sections du résumé
BACKGROUND
Bacillus cereus biovar anthracis (Bcbva) is an emergent bacterium closely related to Bacillus anthracis, the etiological agent of anthrax. The latter has a worldwide distribution and usually causes infectious disease in mammals associated with savanna ecosystems. Bcbva was identified in humid tropical forests of Côte d'Ivoire in 2001. Here, we characterize the potential geographic distributions of Bcbva in West Africa and B. anthracis in sub-Saharan Africa using an ecological niche modeling approach.
METHODOLOGY/PRINCIPAL FINDINGS
Georeferenced occurrence data for B. anthracis and Bcbva were obtained from public data repositories and the scientific literature. Combinations of temperature, humidity, vegetation greenness, and soils values served as environmental variables in model calibrations. To predict the potential distribution of suitable environments for each pathogen across the study region, parameter values derived from the median of 10 replicates of the best-performing model for each pathogen were used. We found suitable environments predicted for B. anthracis across areas of confirmed and suspected anthrax activity in sub-Saharan Africa, including an east-west corridor from Ethiopia to Sierra Leone in the Sahel region and multiple areas in eastern, central, and southern Africa. The study area for Bcbva was restricted to West and Central Africa to reflect areas that have likely been accessible to Bcbva by dispersal. Model predicted values indicated potential suitable environments within humid forested environments. Background similarity tests in geographic space indicated statistical support to reject the null hypothesis of similarity when comparing environments associated with B. anthracis to those of Bcbva and when comparing humidity values and soils values individually. We failed to reject the null hypothesis of similarity when comparing environments associated with Bcbva to those of B. anthracis, suggesting that additional investigation is needed to provide a more robust characterization of the Bcbva niche.
CONCLUSIONS/SIGNIFICANCE
This study represents the first time that the environmental and geographic distribution of Bcbva has been mapped. We document likely differences in ecological niche-and consequently in geographic distribution-between Bcbva and typical B. anthracis, and areas of possible co-occurrence between the two. We provide information crucial to guiding and improving monitoring efforts focused on these pathogens.
Identifiants
pubmed: 32150557
doi: 10.1371/journal.pntd.0008131
pii: PNTD-D-19-00371
pmc: PMC7082064
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0008131Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Mol Aspects Med. 2009 Dec;30(6):356-67
pubmed: 19720074
PLoS Negl Trop Dis. 2016 Sep 08;10(9):e0004923
pubmed: 27607836
Philos Trans R Soc Lond B Biol Sci. 2015 Apr 5;370(1665):
pubmed: 25688023
PLoS Negl Trop Dis. 2016 Jun 09;10(6):e0004689
pubmed: 27280981
PLoS Negl Trop Dis. 2017 Sep 21;11(9):e0005960
pubmed: 28934219
Bioscience. 2017 Jun 1;67(6):534-545
pubmed: 28608869
Emerg Infect Dis. 2011 Mar;17(3):387-94
pubmed: 21392428
Nat Microbiol. 2019 Aug;4(8):1337-1343
pubmed: 31086311
PLoS Negl Trop Dis. 2015 Apr 01;9(4):e0003455
pubmed: 25830379
Clin Infect Dis. 2004 Jul 15;39(2):227-32
pubmed: 15307032
BMC Evol Biol. 2017 Aug 02;17(1):176
pubmed: 28768476
Proc Biol Sci. 2014 Nov 22;281(1795):
pubmed: 25274365
Biol Rev Camb Philos Soc. 2018 Nov;93(4):1813-1831
pubmed: 29732670
Appl Environ Microbiol. 2011 Aug 15;77(16):5818-21
pubmed: 21705535
PLoS Negl Trop Dis. 2016 Apr 20;10(4):e0004637
pubmed: 27097318
PLoS One. 2018 Nov 28;13(11):e0206922
pubmed: 30485342
Bull World Health Organ. 2018 May 01;96(5):327-334
pubmed: 29875517
Rev Sci Tech. 2002 Aug;21(2):359-83
pubmed: 11974621
PLoS Negl Trop Dis. 2015 Aug 20;9(8):e0003931
pubmed: 26291625
J Clin Microbiol. 2006 Sep;44(9):3422-5
pubmed: 16954291
Pan Afr Med J. 2016 Oct 01;25(Suppl 1):14
pubmed: 28149439
J Appl Microbiol. 2019 Jan;126(1):311-323
pubmed: 30253024
Stat Appl Genet Mol Biol. 2010;9:Article39
pubmed: 21044043
PLoS One. 2010 Jul 09;5(7):e10986
pubmed: 20634886
PLoS One. 2017 Feb 16;12(2):e0169748
pubmed: 28207752
Ecol Appl. 2011 Mar;21(2):335-42
pubmed: 21563566
Sci Data. 2017 Jun 20;4:170078
pubmed: 28632236
Am J Primatol. 2006 Sep;68(9):928-33
pubmed: 16900500
Sci Rep. 2016 Jun 06;6:27311
pubmed: 27265371
PLoS One. 2018 May 1;13(5):e0196799
pubmed: 29715287
PLoS One. 2013 Sep 05;8(9):e74816
pubmed: 24040344
PLoS One. 2014 Aug 08;9(8):e100711
pubmed: 25105746
Sci Rep. 2018 Jun 18;8(1):9269
pubmed: 29915251
Arch Intern Med. 2003 Nov 10;163(20):2527-31
pubmed: 14609791
PLoS Med. 2008 Jul 8;5(7):e151
pubmed: 18613747
Infect Immun. 1987 Aug;55(8):1859-61
pubmed: 3112013
Evolution. 2008 Nov;62(11):2868-83
pubmed: 18752605
PLoS Negl Trop Dis. 2017 Oct 13;11(10):e0005885
pubmed: 29028799
Vet Rec. 1977 Jun 25;100(26):573-4
pubmed: 888314
Am J Trop Med Hyg. 2007 Dec;77(6):1103-10
pubmed: 18165531
Onderstepoort J Vet Res. 1994 Mar;61(1):71-83
pubmed: 7898901
Nature. 2004 Jul 22;430(6998):451-2
pubmed: 15269768
Ecosphere. 2017 Aug;8(8):
pubmed: 29276646
Emerg Infect Dis. 2019 May;25(5):947-950
pubmed: 31002072
Am J Trop Med Hyg. 2017 Mar;96(3):550-556
pubmed: 28115677
PeerJ. 2019 Feb 06;7:e6281
pubmed: 30755826
PLoS One. 2017 Jul 13;12(7):e0180930
pubmed: 28704433
Rev Panam Salud Publica. 2013 Aug;34(2):135-6
pubmed: 24096979
Can Vet J. 1995 May;36(5):295-301
pubmed: 7773917
Acta Trop. 2016 Oct;162:114-124
pubmed: 27311387
Nature. 2003 Apr 10;422(6932):611-4
pubmed: 12679788
Science. 1971 Jun 25;172(3990):1303-7
pubmed: 4996306
BMC Public Health. 2018 Jan 5;18(1):106
pubmed: 29304765
PLoS One. 2016 Aug 24;11(8):e0161576
pubmed: 27557120
Acta Vet Scand. 2010 Feb 01;52:7
pubmed: 20122147
Dtsch Arztebl Int. 2012 Dec;109(49):843-8
pubmed: 23267409
Nature. 2017 Aug 2;548(7665):82-86
pubmed: 28770842
J Bacteriol. 2006 Aug;188(15):5333-44
pubmed: 16855222
Int Health. 2017 May 1;9(3):177-183
pubmed: 28582558
Appl Environ Microbiol. 2013 Jun;79(12):3756-61
pubmed: 23584788
Emerg Infect Dis. 2001 Nov-Dec;7(6):933-44
pubmed: 11747719